CURE Today

@cure_today · United States · joined 20 Feb 2009

Cancer updates, research and education for patients with cancer, survivors and their caregivers to become empowered advocates in their journey.

24 939Followers

2 065Following

32 917Posts total

812Views on collected posts

Postingan terbaru

CURE Today@cure_today8 Sep

Join CURE and @ynhhealth for the Educated Patient® Liver Cancer Summit on Saturday, October 17, in New Haven, CT. Register now to learn the latest on liver cancer care: https://t.co/7s8itnqotT https://t.co/vM2IDTiYrB

6 views · 0 likes · 0 reposts · 0 replies Open on X →

CURE Today@cure_today7 Sep

Nominations for the 2027 Extraordinary Healer® Award are open! Help recognize an oncology nurse who goes above and beyond. Nominate by Dec. 9: https://t.co/wJHpW3xRAc #ExtraordinaryHealer #OncologyNurse #CancerCare https://t.co/DUlBl7ICQd

161 views · 0 likes · 2 reposts · 0 replies Open on X →

CURE Today@cure_today7 Sep

Wishing everyone a happy Labor Day! Today, we celebrate the hard work and dedication of those who make a difference every day, including throughout the cancer community. We hope you enjoy a safe and restful #LaborDay 💙 https://t.co/T41OQ1gM2v

157 views · 2 likes · 1 reposts · 0 replies Open on X →

CURE Today@cure_today4 Sep

AI is changing breast cancer care and newer technology can analyze mammograms to help estimate a person’s risk of developing breast cancer in the future. For more visit: https://t.co/H1iM0hIrYx https://t.co/m2UOQYPxDA

140 views · 2 likes · 0 reposts · 2 replies Open on X →

CURE Today@cure_today4 Sep

The FDA granted accelerated approval to Etcamah (camizestrant) for certain HR-positive, HER2-negative breast cancers with ESR1 mutations. Learn what this approval means for patients. https://t.co/jTJdfFwULk https://t.co/HLBjCPOqIX

348 views · 5 likes · 3 reposts · 0 replies Open on X →

Dibandingkan akun berukuran sama

5 postingan dari 90 hari terakhir, dibandingkan dengan rentang 10K–100K pengikut. menjangkau lebih sedikit orang dibanding akun seukurannya.

Median tayangan157akun ini1 026median untuk 10K–100K

Jangkauan, %0.63%akun ini3.75%median untuk 10K–100K

Interaksi, %1.91%akun ini1.68%median untuk 10K–100K

Metrik	Akun ini	Median untuk 10K–100K	Rasio
Median tayangan per postingan	157	1 026	0.15×
Jangkauan (tayangan ÷ pengikut)	0.63%	3.75%	0.17×
Tingkat interaksi	1.91%	1.68%	1.13×

Akun lain pada rentang ini → Bandingkan dengan akun lain → Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3484 Sep

140

1577 Sep

161

68 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

2.30%4 Sep

2.86%

1.91%7 Sep

1.24%

0.00%8 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.68%.

What the audience does

Likes52.9%9 in total

Reposts35.3%6 in total

Replies11.8%2 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.